These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11313919)

  • 1. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.
    Shah N; Thomas TJ; Lewis JS; Klinge CM; Shirahata A; Gelinas C; Thomas T
    Oncogene; 2001 Mar; 20(14):1715-29. PubMed ID: 11313919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of polyamines in the function of nuclear transcription factor NF-kappaB in breast cancer cells.
    Zaletok S; Alexandrova N; Berdynskykh N; Ignatenko N; Gogol S; Orlovsky O; Tregubova N; Gerner E; Chekhun V
    Exp Oncol; 2004 Sep; 26(3):221-5. PubMed ID: 15494691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells.
    Song RX; Zhang Z; Mor G; Santen RJ
    Apoptosis; 2005 May; 10(3):667-78. PubMed ID: 15909128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis.
    Faaland CA; Thomas TJ; Balabhadrapathruni S; Langer T; Mian S; Shirahata A; Gallo MA; Thomas T
    Biochem Cell Biol; 2000; 78(4):415-26. PubMed ID: 11012080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
    Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
    Wang HJ; Wu ZY; Fan P; Bian JM
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
    Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of nuclear factor kappaB by polyamines in breast cancer cells.
    Shah N; Thomas T; Shirahata A; Sigal LH; Thomas TJ
    Biochemistry; 1999 Nov; 38(45):14763-74. PubMed ID: 10555958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling.
    Scherbakov AM; Lobanova YS; Shatskaya VA; Krasil'nikov MA
    Steroids; 2009 Jun; 74(6):535-42. PubMed ID: 19428442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kappa-B nuclear factor and apoptosis of cancerous cells].
    Bentires M
    Bull Mem Acad R Med Belg; 2001; 156(6 Pt 2):329-37. PubMed ID: 11928223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators.
    Weldon CB; Elliott S; Zhu Y; Clayton JL; Curiel TJ; Jaffe BM; Burow ME
    Surgery; 2004 Aug; 136(2):346-54. PubMed ID: 15300201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.